How did shareholders vote on the election of directors?

Shareholders overwhelmingly voted to elect all of Abbott's nominated directors. Each director received a substantial majority of "Votes For" compared to "Votes Withheld," indicating strong shareholder confidence in the current board leadership.

What was the result of the shareholder vote on executive compensation?

The shareholders voted to approve the compensation of Abbott's named executive officers on an advisory basis. Approximately 78.28% of the votes cast were in favor of the compensation, though this vote is non-binding.

What was the shareholder proposal that was rejected?

A shareholder proposal requested that Abbott's Board of Directors adopt a policy requiring the Board Chairman to be an independent director. This proposal was rejected by shareholders, with only 30.76% of the votes cast voting in favor of it.

ABT 8-K: Shareholder Matters

Q: What were the main outcomes of Abbott's Annual Meeting of Shareholders?

The main outcomes included the re-election of all directors, the ratification of Ernst & Young LLP as auditors, and advisory votes on executive compensation and a shareholder proposal regarding board independence. All directors were elected, and executive compensation was approved by a majority of votes cast. However, a proposal for an independent board chairman was rejected.

Summary

This 8-K filing from Abbott Laboratories (ABT) reports the outcomes of its Annual Meeting of Shareholders held on April 27, 2018. The primary focus is on the voting results for key corporate governance matters. Notably, all of Abbott's directors were re-elected, with substantial support in the "Votes For" category across the board. The company's choice of auditors, Ernst & Young LLP, was also ratified by shareholders. Finally, shareholders voted on executive compensation and a shareholder proposal regarding board independence.

Key Highlights

1Abbott Laboratories held its Annual Meeting of Shareholders on April 27, 2018, with results filed on April 30, 2018.
2All nominated directors were successfully elected to the Board of Directors, receiving strong "Votes For" majorities.
3The appointment of Ernst & Young LLP as Abbott's independent auditor for the fiscal year was ratified by shareholders.
4Shareholders approved, on an advisory basis, the compensation of Abbott's named executive officers, with 78.28% of votes cast in favor.
5A shareholder proposal advocating for an independent Board Chairman was rejected, with only 30.76% of votes cast in favor.
6A significant number of broker non-votes were recorded for the director elections and executive compensation vote, indicating shares held in "street name" where instructions were not provided by beneficial owners.

ABBOTT LABORATORIES 8-K Report, Shareholder Vote Results (Apr 30, 2018)

Summary

Key Highlights

Frequently Asked Questions